The injectable formulation uses a depot system: the medication forms a subcutaneous depot that releases semaglutide gradually into your bloodstream over seven days
Your doctor can help you manage both medications in a way that supports your weight loss goals while keeping you healthy
Liquid chromatography-tandem mass spectrometry (LC-MS/MS), which is particularly stable in plasma samples stored at 80C for up to 5 years, can be used to precisely analyze TMAO [5, 85, 86]
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites
Knowing the key differences between semaglutide and tirzepatide is important for anyone who wants to switch between these medicines
Regular check-ins give your provider the chance to adjust dosing, review symptoms, and make sure your plan continues to support both results and drug safety